# Post-Operative Pain 

---

## I. Principles  
- **Multimodal therapy** is standard: use non-opioids, opioids, and regional techniques together when safe.  
- **Start with least invasive options**, escalate stepwise.  
- **Always rule out dangerous causes of pain**: peritonitis, bleeding, compartment syndrome, ischemia.  
- **Oral > IV** whenever possible.  
- **Assess regularly**: numeric scale in verbal patients, CPOT in non-verbal/ICU patients.  
- **Prevent complications**: constipation, oversedation, delirium.  

---

## II. Stepwise Framework  

### Step 1: Scheduled Non-Opioids (baseline for all unless contraindicated)  

- **Acetaminophen**  
  - 650 mg PO q6h OR 1g PO/IV q6–8h  
  - Max 4g/day (3g/day in liver disease, alcohol use, frail patients)  

- **NSAIDs** (Avoid in renal impairment, GI ulcer, coagulopathy, fresh anastomosis)  
  - Ketorolac 15–30 mg IV q6h (max 5 days)  
  - Ibuprofen 400–600 mg PO q6h  
    

- **Adjuncts**  
  - Gabapentin 100–300 mg PO qHS (titrate to 300 TID if tolerated)  
    *Renal dose adjust*
    
  - Robaxin (methocarbamol) 500–1000 mg IV/PO q8h PRN  
    *Limit IV ≤3 days; avoid in severe renal impairment*
    
  - Flexeril (cyclobenzaprine) 5–10 mg PO TID PRN  
    *Caution oversedation*
    
  - Lidocaine patches for incisional pain  

---

### Step 2: PRN Oral Opioids (breakthrough pain)  

- Oxycodone extended release 5–10 mg PO q4–6h PRN
  
- Hydromorphone PO 2–4 mg PO q4–6h PRN
  
- Hydrocodone/APAP (Norco 5/325 mg) 1–2 tabs PO q6h PRN  
  *Track acetaminophen total daily dose*
  
- Tramadol 50 mg PO q6h PRN (max 400 mg/day; serotonin syndrome risk with SSRIs/SNRIs)  

---

### Step 3: IV Opioids (if NPO, severe pain, or unable to tolerate PO)  

- Hydromorphone IV 0.2–0.5 mg IV q2–3h PRN
  
- Morphine IV 1–2 mg IV q2–3h PRN (*avoid in renal impairment*)
  
- Fentanyl IV 25–50 mcg q1–2h PRN (*short acting*)  

---

### Step 4: Escalation / Severe or Refractory Pain  
- **PCA (Patient-Controlled Analgesia)**  
  - Hydromorphone PCA: 0.2 mg demand, lockout 8–10 min, no basal in opioid-naïve  
  - Morphine PCA: 1 mg demand, lockout 8–10 min  
  - Add basal infusion ONLY if opioid-tolerant or ICU monitored
 
 ### Step 5: Acute Pain Service consult
  - Pain uncontrolled despite multimodal regimen  
  - Opioid-tolerant/chronic pain patient  
  - Regional/epidural analgesia is being considered  

- **Regional / Neuraxial**  
  - Epidural infusion (thoracic/lumbar)  
  - TAP block or wound infusion catheter  
  - Coordinate with anesthesia/pain service  



---

## III. Monitoring & Safety  

- **Assessment frequency**  
  - Floor: q4h pain assessment  
  - ICU: q2h (numeric or CPOT if non-verbal)  

- **Side effect management**  
  - Nausea → ondansetron 4 mg IV/PO q8h PRN  
  - Constipation → senna scheduled, add miralax PRN  
  - Pruritus → diphenhydramine or nalbuphine  
  - Respiratory depression → naloxone 0.1–0.2 mg IV q2–3 min PRN (max 0.8 mg)  

- **Special populations**  
  - Elderly, frail → lower doses, slower titration  
  - Renal impairment → avoid morphine, dose-adjust gabapentin, avoid ketorolac  
  - Liver impairment → lower acetaminophen max (≤2–3 g/day)  

---

## IV. Intern Tips
- Always start with **scheduled acetaminophen + NSAID** unless contraindicated.  
- Opioids should be **PRN, not scheduled**.  
- Never exceed **daily acetaminophen max** (account for combo pills).  
- **Reassess pain and vitals** after each escalation step.  
- Disproportionate pain = **consider complication** (bleeding, leak, compartment syndrome).  
- ICU patients: minimize continuous sedation; prioritize analgesia.  
- If delirium develops → minimize opioids/benzos, review meds, add delirium precauations orders. 

---

## V. Quick Reference Tables  

### Non-Opioids  

| Drug | Dose / Route | Notes / Cautions |
|------|--------------|------------------|
| Acetaminophen | 650 mg PO q6h OR 1 g IV q6–8h | Max 4 g/day (3 g in liver dz) |
| Ketorolac | 15–30 mg IV q6h (≤5 days) | Avoid renal/GI/bleeding risk |
| Ibuprofen | 400–600 mg PO q6h | Avoid GI ulcer, renal impairment |
| Gabapentin | 100–300 mg PO qHS → TID | Renal adjust |
| Robaxin | 500–1000 mg IV/PO q8h PRN | Limit IV ≤3 days, avoid severe renal impairment |
| Flexeril | 5–10 mg PO TID PRN | Oversedation risk |
| Lidocaine patch | Apply over incision, 12h on/12h off | Useful for incisional pain |

---

### Opioids  

| Drug | Dose / Route | Notes / Cautions |
|------|--------------|------------------|
| Oxycodone IR | 5–10 mg PO q4–6h PRN | 1st-line oral opioid |
| Hydromorphone PO | 2–4 mg PO q4–6h PRN | Stronger oral option |
| Hydrocodone/APAP | 1–2 tabs PO q6h PRN | Track total APAP dose |
| Tramadol | 50 mg PO q6h PRN (max 400 mg/day) | Risk serotonin syndrome |
| Hydromorphone IV | 0.2–0.5 mg IV q2–3h PRN | Preferred IV opioid |
| Morphine IV | 1–2 mg IV q2–3h PRN | Avoid in renal impairment |
| Fentanyl IV | 25–50 mcg IV q1–2h PRN | Short acting |
| PCA (Hydromorphone) | 0.2 mg demand, lockout 8–10 min | No basal if opioid-naïve |
| PCA (Morphine) | 1 mg demand, lockout 8–10 min | Basal only if opioid-tolerant |

---

## VI. References  

1. Barr J, Fraser GL, Puntillo K, et al. *Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.* Crit Care Med. 2013;41(1):263–306.  
2. Devlin JW, Skrobik Y, Gélinas C, et al. *Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU (PADIS Guidelines).* Crit Care Med. 2018;46(9):e825–e873.  
3. Reade MC, Eastwood GM, Bellomo R, et al. *Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial.* JAMA. 2016;315(14):1460–1468.  

